<DOC>
	<DOCNO>NCT01365962</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research trial study biomarkers tumor tissue sample patient rhabdomyosarcoma .</brief_summary>
	<brief_title>Biomarker Tumor Tissue Samples From Patients With Rhabdomyosarcoma</brief_title>
	<detailed_description>OBJECTIVES : - To determine quantify degree surface insulin-like growth factor I receptor ( IGF-IR ) expression rhabdomyosarcoma ( RMS ) tumor tissue . - To assess feasibility validity mass spectrometry assay IGF-IR expression paraffin-embedded tumor tissue . OUTLINE : Paraffin-embedded tumor tissue slide analyze insulin-like growth factor I receptor ( IGF-1R ) expression mass spectrometry correlate result obtain IHC assay .</detailed_description>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis rhabdomyosarcoma Alveolar embryonal rhabdomyosarcoma Available sample Cooperative Human Tissue Network ( CHTN ) bank PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>alveolar childhood rhabdomyosarcoma</keyword>
	<keyword>embryonal childhood rhabdomyosarcoma</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>previously untreated childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
</DOC>